Pricing Log in Create free account

Kiora Pharmaceuticals, Inc. (KPRX) vs Phio Pharmaceuticals Corp. (PHIO)

Kiora Pharmaceuticals, Inc. and Phio Pharmaceuticals Corp. are both Biotechnology companies. Kiora Pharmaceuticals, Inc. and Phio Pharmaceuticals Corp. are of similar size ($10.8M and $10.7M). Kiora Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 983.7% against 79.0%. Across the 15 metrics below, Kiora Pharmaceuticals, Inc. leads on 11 and Phio Pharmaceuticals Corp. on 4.

Valuation

Metric KPRX PHIO Biotechnology median
P/E n/m n/m 8.50
P/S 0.79 74.31 9.71
P/B 0.88 0.80 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.15 0.20 0.64
EV/Sales (0.10) (19.55) 9.21
Earnings yield (103.07%) (148.28%) (33.15%)
Free cash flow yield (58.10%) (120.77%) (25.50%)

Profitability

Metric KPRX PHIO Biotechnology median
Gross margin 85.06% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (56.36%) (113.71%) (56.36%)
Return on assets (39.43%) (100.78%) (48.04%)
Return on invested capital (44,053.91%) 0.00% 0.00%

Growth

Metric KPRX PHIO Biotechnology median
Revenue growth (TTM) 983.73% 78.95% 6.02%
EPS growth (last fiscal year) (403.45%) 84.03% 30.26%
Revenue growth, 5-year CAGR 88.72% (21.62%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KPRX PHIO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.97 8.39 4.72
Net debt to EBITDA 1.33 2.28 0.96

Dividend

Metric KPRX PHIO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric KPRX PHIO Biotechnology median
Market cap 10.66m 10.75m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack